Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy
about
Modelling hepatitis C therapy--predicting effects of treatmentA hepatitis C virus infection model with time-varying drug effectiveness: solution and analysisSustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics.Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy.
P2860
Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Severity of liver disease affe ...... ravenous silibinin monotherapy
@ast
Severity of liver disease affe ...... ravenous silibinin monotherapy
@en
Severity of liver disease affe ...... ravenous silibinin monotherapy
@nl
type
label
Severity of liver disease affe ...... ravenous silibinin monotherapy
@ast
Severity of liver disease affe ...... ravenous silibinin monotherapy
@en
Severity of liver disease affe ...... ravenous silibinin monotherapy
@nl
prefLabel
Severity of liver disease affe ...... ravenous silibinin monotherapy
@ast
Severity of liver disease affe ...... ravenous silibinin monotherapy
@en
Severity of liver disease affe ...... ravenous silibinin monotherapy
@nl
P2093
P2860
P356
P1433
P1476
Severity of liver disease affe ...... ravenous silibinin monotherapy
@en
P2093
Alan S Perelson
Gonzalo Crespo
Harel Dahari
Jessica M Conway
Massimo D'Amato
Peter Ferenci
Scott J Cotler
Swati DebRoy
Xavier Forns
Zoe Mariño
P2860
P304
P356
10.3851/IMP2806
P577
2014-06-10T00:00:00Z